MERIDIAN BIOSCIENCE INC Quarterly Nonoperating Income (Expense) in USD from Q1 2010 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Meridian Bioscience Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2010 to Q4 2022.
  • Meridian Bioscience Inc Nonoperating Income (Expense) for the quarter ending December 31, 2022 was -$982K, a 84.6% decline year-over-year.
  • Meridian Bioscience Inc Nonoperating Income (Expense) for the twelve months ending December 31, 2022 was -$524K, a 80.6% increase year-over-year.
  • Meridian Bioscience Inc annual Nonoperating Income (Expense) for 2022 was -$74K, a 97.1% increase from 2021.
  • Meridian Bioscience Inc annual Nonoperating Income (Expense) for 2021 was -$2.58M, a 27.2% decline from 2020.
  • Meridian Bioscience Inc annual Nonoperating Income (Expense) for 2020 was -$2.03M, a 77.8% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$524K -$982K -$450K -84.6% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-09
Q3 2022 -$74K -$15K +$618K +97.6% Jul 1, 2022 Sep 30, 2022 10-K 2022-11-22
Q2 2022 -$692K $79K +$464K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 -$1.16M $394K +$1.54M Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q4 2021 -$2.7M -$532K -$116K -27.9% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 -$2.58M -$633K +$1.09M +63.3% Jul 1, 2021 Sep 30, 2021 10-K 2022-11-22
Q2 2021 -$3.68M -$385K -$593K -285% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$3.08M -$1.15M -$2.01M -234% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$1.08M -$416K +$952K +69.6% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-04
Q3 2020 -$2.03M -$1.73M -$1.23M -250% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-22
Q2 2020 -$797K $208K +$194K +1386% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$991K $856K +$1.44M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$2.44M -$1.37M -$1.29M -1724% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-05
Q3 2019 -$1.14M -$493K -$261K -113% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-23
Q2 2019 -$881K $14K +$129K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$1.01M -$588K -$134K -29.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$876K -$75K +$328K +81.4% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-07
Q3 2018 -$1.2M -$232K -$59K -34.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-11-23
Q2 2018 -$1.15M -$115K +$243K +67.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$1.39M -$454K -$458K -11450% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$930K -$403K +$23K +5.4% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
Q3 2017 -$953K -$173K -$30K -21% Jul 1, 2017 Sep 30, 2017 10-K 2019-11-26
Q2 2017 -$923K -$358K -$18K -5.29% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$905K $4K +$368K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$1.27M -$426K -$539K -477% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q3 2016 -$734K -$143K -$20K -16.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-11-29
Q2 2016 -$714K -$340K -$247K -266% Mar 25, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$467K -$364K -$159K -77.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$308K $113K +$689K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 -$997K -$123K -$329K -160% Jul 1, 2015 Sep 30, 2015 10-K 2017-11-29
Q2 2015 -$668K -$93K +$159K +63.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$827K -$205K -$183K -832% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$644K -$576K -$360K -167% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 -$284K $206K +$421K Jul 1, 2014 Sep 30, 2014 10-K 2016-11-29
Q2 2014 -$705K -$252K -$104K -70.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$601K -$22K -$298K -108% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$303K -$216K -$351K -260% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 $48K -$215K -$304K -342% Jul 1, 2013 Sep 30, 2013 10-K 2015-11-30
Q2 2013 $352K -$148K -$193K -429% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $545K $276K +$311K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $234K $135K -$186K -57.9% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-10
Q3 2012 $420K $89K +$49K +123% Jul 1, 2012 Sep 30, 2012 10-K 2014-12-01
Q2 2012 $371K $45K -$17K -27.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $388K -$35K -$180K -124% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $568K $321K +$101K +45.9% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-11
Q3 2011 $467K $40K Jul 1, 2011 Sep 30, 2011 10-K 2013-11-29
Q2 2011 $62K +$42K +210% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $145K +$5K +3.57% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 $220K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-09
Q2 2010 $20K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
Q1 2010 $140K Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.